Header

At Novartis, we believe that biomedical innovation will have an unparalleled impact on all humankind. We are excited at being leaders in this, and we are constantly looking for partners who want to share the journey with us.

50%

of our revenues come from external sourced opportunities ...

100+

... made possible by 100+ business Development & Licensing professionals ...

6 000

... backed up by 6000 Scientists

Partnering opportunities

Novartis is uniquely diversified across therapy areas with exposure to cutting-edge technology platforms. We have arguably the richest and broadest pipeline in the industry with more than 65 New Molecular Entities in development.

Please select your therapy area of interest to connect to one of our specialist, partnering professionals.

Scientist kneeling in a lab

Innovative Medicines

Novartis Pharmaceuticals and Novartis Oncology research, develop and commercialize Innovative Medicines to enhance health outcomes for patients and HCPs.

Close up of a set of pills

Generics & Biosimilars

Our Sandoz Division is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.

Two persons looking at a smartphone

Digital Solutions

Building a leading digital and data science platform through bold partnerships with industry leaders, and continuous investment in people and data management.

Phil Gotwals discusses advanced therapy platforms.

Sourcing innovation, strategically

Phil Gotwals, the Head of BD&L at NIBR, talks about his vision for the future of business development for research.

Group of business people working in a meeting room

The Novartis Biome

A catalyst for impactful digital collaboration to create better healthcare solutions and seamless experiences for patients and caregivers, at scale.